The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until September, 2020.
SBC: BIOPROTECTION SYSTEMS CORP. Topic: CBD08105
The objective of this study is to demonstrate the efficacy and broad applicability of the human immune-modulating alphaGal Adjuvant Technology for antiviral vaccine development. We will use viral vaccine candidates for the select Category A viral pathogens Zaire ebolavirus (ZEBOV, filovirus), Rift Valley fever virus (RVFV, bunyavirus), and Lassa virus (LV, arenavirus), to evaluate the adjuvant pot ...SBIR Phase I 2008 Department of DefenseOffice for Chemical and Biological Defense
SBC: SCIENCE & ENGINEERING SERVICES, INC. Topic: CBD08104
We propose to build a compact laser photoacoustic spectrometric (LPAS) sensor for continuous, real-time broadband analysis of multiple chemical components, and perform field tests to qualify it for dynamic monitoring of chemical warfare agents (CWA). Our sensor will be based on our laboratory LPAS instrument (at technology readiness level TRL-4) that has already demonstrated successful multicompon ...SBIR Phase I 2008 Department of DefenseOffice for Chemical and Biological Defense